In December 2023 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Tanzanian bodybuilder Obadia Andabwile Mwampeta after his sample tested positive for the prohibited substances 19-norandrosterone (Nandrolone), and Stanozolol.
Following notification ADAK was unable to locate the Athlete and he failed to respond. Thereupon the case was referred to the Kenya Sports Disputes Tribunal and a decision was rendered based on the written submissions of the Parties.
In view of the evidence the Panel finds that the presence of multiple prohibited substances have been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.
Without the Athlete's response the Panel deems that he failed to demonstrate that the violation was not intentional, nor how the substances had entered his system. Furthermore the Panel finds that there are no grounds for a reduced sanction.
Therefore the Panel decides on 2 May 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the decision.
